MILWAUKEE, Jan. 10, 2005 — To help manufacturers in the life sciences industry better understand the U.S. Food and Drug Administration’s Process Analytical Technology (PAT) initiative, Rockwell Automation today released a white paper providing a detailed look at the business drivers of PAT – regulatory and financial – and highlighting fundamental steps to successful implementation.
Entitled “PAT Initiative Expected to Invigorate Pharmaceutical Industry with Improved Quality, Better Efficiency and Improved Profits,” the white paper can be downloaded free at www.rockwellautomation.com/lifesciences . “The underlying premise of PAT is that quality cannot be tested into products; instead, product quality should be built-in and inherent in product design,” said Glenn Restivo, Life Sciences Industry Solutions marketing manager, Rockwell Automation. “With the release of this white paper, Rockwell Automation is helping customers better understand PAT, which encourages the application of advanced analytical tools to improve manufacturing efficiency and strengthen product quality.
Such strategies can help companies lower production cycle times, reduce the number of rejected products, improve product quality and maximize the use of production assets.” The FDA’s new PAT initiative aims to foster improvements in manufacturing efficiency and product quality while creating a harmonization of regulatory expectations.
PAT provides a framework for designing, analyzing and controlling manufacturing through timely measurements of raw and in-process materials to help ensure desired product quality.Rockwell Automation offers innovative control, information and MES solutions to help companies confront key issues and challenges – such as flexible manufacturing, Process Analytical Technologies (PAT), Radio Frequency Identification (RFID) and current and future FDA regulations and initiatives – to positively impact business drivers, improve quality in the manufacturing process, help meet regulatory compliance and reduce time-to-market.
To receive a free copy of Rockwell Automation’s new white paper, call 800.223.5354, Ext. 1774, or visit www.rockwellautomation.com/lifesciences .Rockwell Automation (NYSE: ROK) is a world-leading provider of industrial automation power, control and information solutions that help customers meet their manufacturing productivity objectives.
The company brings together leading brands in industrial automation for Complete Automation® solutions, including Allen-Bradley® controls and engineered services and Rockwell Software® factory management software, Dodge® mechanical power transmission products, and Reliance Electric® motors and drives. The company also is a leading provider of contact management technologies and applications that help companies more efficiently manage interaction with their own customers. Headquartered in Milwaukee, Wis., USA, the company employs about 22,000 people serving customers in more than 80 countries.
